These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1325 related articles for article (PubMed ID: 30266679)

  • 1. Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration.
    Masaldan S; Bush AI; Devos D; Rolland AS; Moreau C
    Free Radic Biol Med; 2019 Mar; 133():221-233. PubMed ID: 30266679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.
    Devos D; Cabantchik ZI; Moreau C; Danel V; Mahoney-Sanchez L; Bouchaoui H; Gouel F; Rolland AS; Duce JA; Devedjian JC;
    J Neural Transm (Vienna); 2020 Feb; 127(2):189-203. PubMed ID: 31912279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis: A potential therapeutic target for neurodegenerative diseases.
    Vitalakumar D; Sharma A; Flora SJS
    J Biochem Mol Toxicol; 2021 Aug; 35(8):e22830. PubMed ID: 34047408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis and its potential role in the physiopathology of Parkinson's Disease.
    Mahoney-Sánchez L; Bouchaoui H; Ayton S; Devos D; Duce JA; Devedjian JC
    Prog Neurobiol; 2021 Jan; 196():101890. PubMed ID: 32726602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox active metals in neurodegenerative diseases.
    Acevedo K; Masaldan S; Opazo CM; Bush AI
    J Biol Inorg Chem; 2019 Dec; 24(8):1141-1157. PubMed ID: 31650248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease.
    Jakaria M; Belaidi AA; Bush AI; Ayton S
    J Neurochem; 2021 Dec; 159(5):804-825. PubMed ID: 34553778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer's and Parkinson's diseases.
    Singh YP; Pandey A; Vishwakarma S; Modi G
    Mol Divers; 2019 May; 23(2):509-526. PubMed ID: 30293116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides.
    Singh K; Gupta JK; Kumar S; Soni U
    Curr Protein Pept Sci; 2024; 25(7):507-526. PubMed ID: 38561605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron and Ferroptosis as Therapeutic Targets in Alzheimer's Disease.
    Gleason A; Bush AI
    Neurotherapeutics; 2021 Jan; 18(1):252-264. PubMed ID: 33111259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis Mechanisms Involved in Neurodegenerative Diseases.
    Reichert CO; de Freitas FA; Sampaio-Silva J; Rokita-Rosa L; Barros PL; Levy D; Bydlowski SP
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron in neurodegenerative disorders: being in the wrong place at the wrong time?
    Apostolakis S; Kypraiou AM
    Rev Neurosci; 2017 Nov; 28(8):893-911. PubMed ID: 28792913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer's Disease, Amyotrophic Lateral Sclerosis and Aging.
    Kupershmidt L; Youdim MBH
    Cells; 2023 Feb; 12(5):. PubMed ID: 36899898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron and Ferroptosis More than a Suspect: Beyond the Most Common Mechanisms of Neurodegeneration for New Therapeutic Approaches to Cognitive Decline and Dementia.
    Cerasuolo M; Di Meo I; Auriemma MC; Trojsi F; Maiorino MI; Cirillo M; Esposito F; Polito R; Colangelo AM; Paolisso G; Papa M; Rizzo MR
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators.
    Weinreb O; Mandel S; Youdim MBH; Amit T
    Free Radic Biol Med; 2013 Sep; 62():52-64. PubMed ID: 23376471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological metals and metal-targeting compounds in major neurodegenerative diseases.
    Barnham KJ; Bush AI
    Chem Soc Rev; 2014 Oct; 43(19):6727-49. PubMed ID: 25099276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transition metals copper and iron in neurodegenerative diseases.
    Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
    Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mini-Review: Is iron-mediated cell death (ferroptosis) an identical factor contributing to the pathogenesis of some neurodegenerative diseases?
    Viktorinova A; Durfinova M
    Neurosci Lett; 2021 Feb; 745():135627. PubMed ID: 33440237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional brain iron associated with deterioration in Alzheimer's disease: A large cohort study and theoretical significance.
    Ayton S; Portbury S; Kalinowski P; Agarwal P; Diouf I; Schneider JA; Morris MC; Bush AI
    Alzheimers Dement; 2021 Jul; 17(7):1244-1256. PubMed ID: 33491917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferroptosis, a Recent Defined Form of Critical Cell Death in Neurological Disorders.
    Wu JR; Tuo QZ; Lei P
    J Mol Neurosci; 2018 Oct; 66(2):197-206. PubMed ID: 30145632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.